Thromb Haemost 2014; 111(02): 378-380
DOI: 10.1160/TH13-06-0525
Letters to the Editor
Schattauer GmbH

Anti-oxidised-phospholipid antibodies do not correlate with specific anti-phospholipid syndrome classes, but with disease duration

Claudio Musetti
1   Department of Translational Medicine, University “Amedeo Avogadro” of East Piedmont, Novara, Italy
,
Marco Quaglia
1   Department of Translational Medicine, University “Amedeo Avogadro” of East Piedmont, Novara, Italy
,
Tiziana Cena
2   Epidemiology, University “Amedeo Avogadro” of East Piedmont, Novara, Italy
,
Antonietta Rizzo
1   Department of Translational Medicine, University “Amedeo Avogadro” of East Piedmont, Novara, Italy
,
Piero Stratta
1   Department of Translational Medicine, University “Amedeo Avogadro” of East Piedmont, Novara, Italy
,
Emanuele Albano
3   Department of Health Sciences, University “Amedeo Avogadro” of East Piedmont, Novara, Italy
› Author Affiliations
Further Information

Publication History

Received: 30 June 2013

Accepted after major revision: 23 September 2013

Publication Date:
27 November 2017 (online)

 

 
  • References

  • 1 Canavese C, Stratta P, Vercellone A. Oxygen free radicals in nephrology. Int J Artif Organs 1987; 10: 379-389.
  • 2 Stratta P, Canavese C, Dogliani M. et al. The role of free radicals in the progression of renal disease. AM J Kidney Dis 1991; 17: 33-37.
  • 3 Horkko S, Miller E, Branch DW. et al. The epitopes for some antiphospholipid antibodies are adducts of oxideted phospholipids and β2glicoprotein I. Proc Natl Acad Sci USA 1997; 94: 10356-10361.
  • 4 Vidali M, Hietala J, Occhino G. et al. Immune responses against oxidative stress-derived antigens are associated with increased circulating tumor necrosis factor-alpha in heavy drinkers. Free Radic Biol Med 2008; 45: 306-311.
  • 5 Savill J, Dransfield I, Gregory C. et al. A blast from the past: clearance of apoptotic cells regulates immune responses. Nat Rev Immunol 2002; 2: 965-975.
  • 6 Rovere-Querini P, Dimitriu IE. Corpse disposal after apoptosis. Apoptosis 2003; 8: 469-479.
  • 7 Samhan-Arias AK, Ji J, Demidova OM. et al. Oxidized phospholipids as biomarkers of tissue and cell damage with a focus on cardiolipin. Biochim Biophys Acta 2012; 1818: 2413-2423.
  • 8 Miyakis S, Lockshin MD, Atsumi T. et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 2006; 4: 295-306.
  • 9 Rolla R, Vay D, Mottaran E. et al. Antiphospholi-pid antibodies associated with alcoholic liver disease specifically recognise oxidised phospholipids. Gut 2001; 49: 852-859.
  • 10 Vay D, Rigamonti C, Vidali M. et al. Anti-phos-pholipid antibodies associated with alcoholic liver disease target oxidized phosphatidylserine on apoptotic cell plasma membranes. J Hepatol 2006; 44: 183-189.
  • 11 Rolla R, Vidali M, Serino R. et al. Antibodies against oxidized phospholipids in laboratory tests exploring lupus anti-coagulant activity. Clin Exp Immunol 2007; 149: 63-69.
  • 12 Ruiz-Irastorza G, Crowther M, Branch W. et al. Antiphospholipid syndrome. Lancet 2010; 376: 1498-1509.
  • 13 Amitrano L, Ames PR, Guardascione MA. et al. Antiphospholipid antibodies and antiphospholipid syndrome: role in portal vein thrombosis in patients with and without liver cirrhosis. Clin Appl Thromb Hemost 2011; 17: 367-370.
  • 14 Su J, Hua X, Vikström M. et al. Low levels of IgM antibodies to oxidized cardiolipin increase and high levels decrease risk of cardiovascular disease among 60-year olds: a prospective study. BMC Cardiovasc Disord 2013; 13: 1.
  • 15 Sciascia S, Murru V, Sanna G. et al. Clinical accuracy for diagnosis of antiphospholipid syndrome in systemic lupus erythematosus: evaluation of 23 possible combinations of antiphospholipid antibody specificities. J Thromb Haemost 2012; 10: 2512-2518.